Clinical Trial Update: An Open-Label Study of the Effect of Telaprevir in Combination With Peginterferon Alfa-2b and Ribavirin in Pediatric Subjects Infected With Hepatitis C Virus [Phase 1, Phase 2]

View source ↗

Summary

Open-label Phase 1/2 trial of telaprevir in combination with peginterferon alfa-2b and ribavirin in pediatric patients with Hepatitis C was terminated; results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Peginterferon alfa-2b (Peginterferon alfa-2b)
• Ribavirin (ribavirin)
• Telaprevir (telaprevir)

Snippet

Sponsor: Vertex Pharmaceuticals Incorporated | Conditions: Hepatitis C | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2016-07-20